Machine Learning–Based Comparative Analysis of Blood Cell–Derived Inflammatory Indices for Predicting MAFLD and Liver Fibrosis: Evidence From NHANES 2017–2020
Journal of Clinical Laboratory Analysis · 2026
DOI: 10.1002/jcla.70349 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Clinical Laboratory Analysis, 2026. Verfasst von Hao Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, Jiangsu, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Machine Learning, Inflammation, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metabolic dysfunction associated fatty liver disease (MAFLD) is linked to chronic low‐grade inflammation, but the diagnostic value of blood cell–derived inflammatory indices remains unclear. This study assessed their associations and predictive ability for MAFLD and liver fibrosis in a nationally representative population.
Methods
This cross‐sectional study included 3501 participants from NHANES 2017–2020. Multivariable logistic regression was used to evaluate associations between six inflammatory indices (AISI, NLR, LMR, PLR, SII and SIRI) and MAFLD with or without liver fibrosis. Restricted cubic spline analysis assessed dose–response relationships, while receiver operating characteristic (ROC) curves and random forest analysis evaluated diagnostic performance and variable importance.
Results
Multivariable logistic regression analysis showed that higher values of ln (AISI) and ln (SIRI) were significantly associated with increased odds of MAFLD, whereas ln (SII), ln (LMR) and ln (NLR) were not significantly associated with MAFLD ( p > 0.05). In contrast, ln (PLR) was inversely associated with MAFLD. Among participants with liver fibrosis (LF), higher values of ln (AISI), ln (NLR) and ln (SIRI) were positively associated with MAFLD, whereas ln (PLR) remained inversely associated. No significant associations were observed for ln (LMR) or ln (SII) with MAFLD in the presence of LF. Among the evaluated inflammatory indices, AISI demonstrated the highest discriminatory performance for MAFLD (AUC = 0.752), whereas PLR showed the best performance for predicting liver fibrosis. These findings were further supported by machine learning analysis.
Conclusion
Inflammatory indices showed distinct associations with MAFLD and liver fibrosis. AISI was most strongly associated with MAFLD, whereas PLR showed the best performance for fibrosis assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, Jiangsu, China.
- The First Clinical Medical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China.
ORCID-Profile: Hao Chen, Qinmei Chen, Xiangqian Wang, Yixian He, Xiqiao Zhou
Zitieren
APA
Chen, H., Chen, Q., Wang, X., He, Y., & Zhou, X. (2026). Machine Learning–Based Comparative Analysis of Blood Cell–Derived Inflammatory Indices for Predicting MAFLD and Liver Fibrosis: Evidence From NHANES 2017–2020. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70349
Vancouver
Chen H, Chen Q, Wang X, He Y, Zhou X. Machine Learning–Based Comparative Analysis of Blood Cell–Derived Inflammatory Indices for Predicting MAFLD and Liver Fibrosis: Evidence From NHANES 2017–2020. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70349
BibTeX
@article{Chen2026,
author = {Chen, Hao and Chen, Qinmei and Wang, Xiangqian and He, Yixian and Zhou, Xiqiao},
title = {Machine Learning–Based Comparative Analysis of Blood Cell–Derived Inflammatory Indices for Predicting MAFLD and Liver Fibrosis: Evidence From NHANES 2017–2020},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
doi = {10.1002/jcla.70349}
}
EUVIMED